Rheum for Everyone, Episode 24 (video)| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How to Diagnose Sjögren’s Disease

Samantha C. Shapiro, MD  |  August 26, 2025

TR: So would you recommend objective dryness testing in patients with an ANA of 1:160 and fibromyalgia symptoms but no dryness?

CJ: Yes, I absolutely would. If there is a reasonable chance that a patient could have SjD, I wouldn’t want to miss it. I would do a Schirmer’s test and sialometry in the office and then consider sending the patient to one of our cornea specialists for further testing. Using a slit lamp, fluorescence and lissamine green, they are able to report an ocular staining score (OSS), which is more sensitive for early dry eye changes than Schirmer testing.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

TR: How do you diagnose seronegative SjD?

DD: Diagnosing seronegative SjD requires a minor salivary gland biopsy (lip biopsy).2

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

TR: How is seronegative SjD different than seropositive SjD?

DD: Seropositive SjD is associated with more inflammation on labs. These are the patients with very high immunoglobulins, high inflammatory markers, hypocomp-lementemia and a positive rheumatoid factor. They have a lot of glandular swelling. They have high-grade inflammatory lesions on salivary gland ultrasound and an increased risk of lymphoma.

On the other hand, seronegative SjD patients tend to have normal labs and less organ involvement, but more neurologic findings like small fiber neuropathy and postural orthostatic tachycardia syndrome (POTS) symptoms.

I think in 10 years, we’re going to understand these entities much better with possibly even two different underlying mechanisms. It may be that they are two different pathophysiologic processes, and that’s what’s making the clinical trials hard. There are various mechanisms of action that could be coming into play. For example, dysautonomia could be part of the pathogenesis that is part of the dryness seen in patients without positive serologies.

CJ: In my mind, seropositivity is associated with more badness—significant organ manifestations, like ILD [interstitial lung disease], kidney disease and lymphoma. But seronegative patients can still develop any of these things. In this regard, you can think of it like rheumatoid arthritis (RA). Seropositive RA patients have a greater risk of developing extra-articular manifestations, but the seronegative patients can get these too.

TR: As you know, not all patients referred to us for dryness have SjD. What else is on your differential in these cases?

DD: Medications are the most common cause of dryness overall. Common culprits include tricyclic anti-depressants, over­active bladder medications, diuretics, antihistamines … the list goes on. There’s a great UpToDate article on this.

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:ConditionsGuidancePractice SupportSjögren’s Disease Tagged with:biopsyDry eyeDry MouthDysautonomiaFibromyalgiaInterstitial Lung DiseaselymphomasiccaSjögren’s Disease supplementUltrasound

Related Articles

    What Rheumatologists Need to Know about Diagnosing and Managing Interstitial Lung Disease (ILD)

    December 1, 2012

    Patients with systemic sclerosis (SSc), poly-/dermatomyositis (PM/DM), or rheumatoid arthritis (RA) appear to carry the greatest risk for developing connective tissue disease-associated interstitial lung disease (CTD-ILD)
     

    How the Experts Treat Sjögren’s Disease

    August 26, 2025

    With no FDA-approved drugs for Sjögren’s disease, experts share strategies for managing fatigue, arthritis, dryness, and systemic issues.

    A Sound Diagnosis for Glandular Swelling

    August 26, 2025

    In this case study, ultrasonography proves useful for excluding a diagnosis of Sjögren’s disease, leading to a correct diagnosis of IgG4-RD.

    Image Case Report: Glandular Swelling

    November 8, 2023

    The Case A 47-year-old woman presented with a one-year history of bilateral submandibular gland swelling, mild symptoms of xerostomia and xerophthalmia and arthralgias in her fingers. A review of systems was otherwise unremarkable. On physical examination, her submandibular glands on both sides were enlarged and had a firm texture. Her parotid glands were normal, as…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences